Načítá se...
Refractory acute promyelocytic leukemia successfully treated with combination therapy of arsenic trioxide and tamibarotene: A case report
A 40-year-old male developed refractory acute promyelocytic leukemia (APL) after various treatments including all-trans retinoic acid, tamibarotene, arsenic trioxide (As(2)O(3)), conventional chemotherapy, and autologous peripheral blood stem cell transplantation. We attempted to use both tamibarote...
Uloženo v:
| Vydáno v: | Leuk Res Rep |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4840419/ https://ncbi.nlm.nih.gov/pubmed/27144119 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lrr.2016.01.001 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|